Author Question: A researcher gives half of her participants a new anti-anxiety pill and the other half a placebo ... (Read 112 times)

lb_gilbert

  • Hero Member
  • *****
  • Posts: 588
A researcher gives half of her participants a new anti-anxiety pill and the other half a placebo pill. She does not tell participants whether they have received an active treatment pill or a sugar pill. This is an example of what type of study?
 
  a. a prospective study
  b. a single-blind study
  c. a double-blind study
  d. a observational study

Question 2

A subject in your study correctly assumes that you are interested in whether people behave in a prejudicial way towards people of a homosexual orientation. She then goes out of her way to act friendly and nice. This represents an example of ______________
 
  a. the placebo effect
  b. participant bias
  c. error
  d. experimenter bias


pocatato

  • Sr. Member
  • ****
  • Posts: 333
Answer to Question 1

Answer: b

Answer to Question 2

Answer: b



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Of the estimated 2 million heroin users in the United States, 600,000–800,000 are considered hardcore addicts. Heroin addiction is considered to be one of the hardest addictions to recover from.

Did you know?

You should not take more than 1,000 mg of vitamin E per day. Doses above this amount increase the risk of bleeding problems that can lead to a stroke.

Did you know?

Before a vaccine is licensed in the USA, the Food and Drug Administration (FDA) reviews it for safety and effectiveness. The CDC then reviews all studies again, as well as the American Academy of Pediatrics and the American Academy of Family Physicians. Every lot of vaccine is tested before administration to the public, and the FDA regularly inspects vaccine manufacturers' facilities.

Did you know?

Intradermal injections are somewhat difficult to correctly administer because the skin layers are so thin that it is easy to accidentally punch through to the deeper subcutaneous layer.

Did you know?

Though Candida and Aspergillus species are the most common fungal pathogens causing invasive fungal disease in the immunocompromised, infections due to previously uncommon hyaline and dematiaceous filamentous fungi are occurring more often today. Rare fungal infections, once accurately diagnosed, may require surgical debridement, immunotherapy, and newer antifungals used singly or in combination with older antifungals, on a case-by-case basis.

For a complete list of videos, visit our video library